Expanding the Spectrum of Ubiquitin-specific Proteases-Fused Neoplasms
Mesenchymal spindle cell tumors represent a heterogeneous group of neoplasms defined by distinct clinicopathologic features and diverse molecular alterations. While USP6 rearrangements are well-established in nodular fasciitis and related entities, fusions involving other ubiquitin-specific proteases, such as USP2 and USP8, have only recently emerged. Prompted by sporadic reports of USP8 fusions in matrix-rich neoplasms, we aimed to characterize the clinicopathologic and molecular spectrum of USP2/USP8-rearranged mesenchymal tumors. We retrospectively analyzed 19 tumors, evaluating clinical, histopathologic features, immunohistochemical profiles, whole-transcriptome RNA sequencing, and DNA methylation profiling. Nineteen tumors were identified, harboring either USP8 (n=12) or USP2 (n=7) fusions. The cohort included patients aged 3 to 70 years (median: 32). Tumors primarily affected the distal extremities, with the notable exception of 2 intracardiac cases in pediatric patients, harboring USP8 fusions (CBLB::USP8 and SPPL2A::USP8). Histologically, all cases were composed of bland spindle cells arranged in either a myofibromatous or an inflammatory pattern; notably, USP2-fused tumors exhibited an exclusively myofibromatous morphology. Immunohistochemically, SMA was frequently expressed, while desmin, h-caldesmon, ALK, ROS1, panTRK, and CD34 were consistently negative. Transcriptomic analysis demonstrated proximity to myofibroma and nodular fasciitis profiles, rather than forming a distinct USP2/8-specific cluster. No cases showed malignant behavior or recurrence during the available follow-up period. USP2/8-rearranged neoplasms represent a morphologically diverse but biologically indolent subset of myofibroblastic tumors. They exhibit significant overlap with USP6-associated lesions and PDGFR-altered myofibromas. Recognizing these fusions is critical to avoid diagnostic pitfalls and overtreatment, particularly when they present in unusual sites, such as the heart.
Authors
- Aline Baltrès (ORCID: https://orcid.org/0009-0008-7949-0036)
- Nicolas Macagno (ORCID: https://orcid.org/0000-0002-9882-2162)
- Alexandra Meurgey (ORCID: https://orcid.org/0009-0003-8568-8640)
- Aurélie Houlier
- F. Le Loarer
- Jeremy Garcia
- Diane Frankel (ORCID: https://orcid.org/0000-0003-3321-6951)
- Franck Tirode (ORCID: https://orcid.org/0000-0003-4731-7817)
- Sophie El Zein (ORCID: https://orcid.org/0000-0001-6630-0020)
- Gaëlle Pierron (ORCID: https://orcid.org/0000-0002-2536-7680)
- Marie Karanian (ORCID: https://orcid.org/0000-0003-0434-636X)
- Delphine Guillemot
- Daniel Pissaloux
- Corinne Bouvier
- Anne-Claire Marsan-Fratini
- Sarah Watson
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- Université de Bordeaux (FR)
- Inserm (FR)
- Aix-Marseille Université (FR)
- Université Paris Sciences et Lettres (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
- Centre Léon Bérard (FR)
- Centre de Recherche en Cancérologie de Lyon (FR)
- Institut Bergonié (FR)
- International Drug Development (FR)
- Hôpital de la Timone (FR)
- French Clinical Research Infrastructure Network (FR)
- BoRdeaux Institute of onCology (FR)
- Institut Curie (FR)
Publication Details
- Journal
- The American Journal of Surgical Pathology
- Published
- 2026-04-22
- DOI
- https://doi.org/10.1097/pas.0000000000002557
- Primary Topic
- Soft tissue tumor case studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00